Company / Profit Margin
LENZ Therapeutics, Inc. Profit Margin History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-430.3%
FY2025
5-year range
-430.3% / -430.3%
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#120 of 146
Health Care
What the data says
LENZ Therapeutics, Inc.'s profit margin of -430.3% is lower than 82% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
-430.3% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 146This company -430.3% Sector average -796.3%
▼
+46.0% above sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -430.3% | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026